Repare Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell RPTX and other ETFs, options, and stocks.About RPTX
Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company was founded by Daniel Durocher, Agnel Sfeir and Frank Sicheri on September 6, 2016 and is headquartered in Saint-Laurent, Canada.
CEOSteve Forte
CEOSteve Forte
Employees129
Employees129
HeadquartersSaint-Laurent, Québec
HeadquartersSaint-Laurent, Québec
Founded2016
Founded2016
Employees129
Employees129
RPTX Key Statistics
Market cap111.00M
Market cap111.00M
Price-Earnings ratio-1.52
Price-Earnings ratio-1.52
Dividend yield—
Dividend yield—
Average volume2.08M
Average volume2.08M
High today$2.63
High today$2.63
Low today$2.56
Low today$2.56
Open price$2.62
Open price$2.62
Volume920.96K
Volume920.96K
52 Week high$2.66
52 Week high$2.66
52 Week low$0.89
52 Week low$0.89
Stock Snapshot
As of today, Repare Therapeutics(RPTX) shares are valued at $2.58. The company's market cap stands at 111M, with a P/E ratio of -1.52.
As of 2026-01-03, Repare Therapeutics(RPTX) stock has fluctuated between $2.56 and $2.63. The current price stands at $2.58, placing the stock +0.8% above today's low and -1.7% off the high.
The Repare Therapeutics(RPTX)'s current trading volume is 920.96K, compared to an average daily volume of 2.08M.
In the last year, Repare Therapeutics(RPTX) shares hit a 52-week high of $2.66 and a 52-week low of $0.89.
In the last year, Repare Therapeutics(RPTX) shares hit a 52-week high of $2.66 and a 52-week low of $0.89.
People also own
Based on the portfolios of people who own RPTX. This list is generated using Robinhood data, and it’s not a recommendation.